Program linked to medical oncology practice improvement

April 6, 2013
Program linked to medical oncology practice improvement
For medical oncology practices in the United States, participation in the American Society of Clinical Oncology's Quality Oncology Practice Initiative correlates with improvements in measured performance, especially with regard to newly introduced clinical information, according to research published online March 11 in the Journal of Clinical Oncology.

(HealthDay)—For medical oncology practices in the United States, participation in the American Society of Clinical Oncology's Quality Oncology Practice Initiative (QOPI) correlates with improvements in measured performance, especially with regard to newly introduced clinical information, according to research published online March 11 in the Journal of Clinical Oncology.

Michael N. Neuss, M.D., of the Vanderbilt University Medical Center in Nashville, Tenn., and colleagues surveyed 156 medical oncology practices in the United States to determine whether QOPI scores have improved over time and, if so, which factors were associated with improvement.

From 2006 to 2010, average adherence to for the medical oncology practices surveyed improved from 0.71 to 0.85. Many measures did not change over time. However, the greatest improvement was seen in the introduction of new clinical information. The least improvement was seen in the management of symptoms/toxicity. Overall adherence to quality care standards was highest in and lowest in non-small cell lung cancer.

"In summary, QOPI provides a structure for oncology practice group self-examination that has been widely adopted and shows practice improvement over time," the authors write. "The absence of improvement in which wide performance gaps remain in some specific areas demonstrates the opportunity to cross the quality chasm. The development of tools and incentives to inspire the improvement are obvious and important next steps."

Two authors disclose payments or honoraria received in connection with the study.

Explore further: Michigan cancer programs follow care guidelines for common cancers, study finds

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Michigan cancer programs follow care guidelines for common cancers, study finds

April 10, 2012
A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.

A nurse practitioner-driven palliative care intervention improves cancer patients' quality of life

May 18, 2012
Recent studies have shown that palliative care interventions aimed at addressing patients' emotional, spiritual and social needs have a significant impact on cancer patients' quality of life and may even improve cancer patients' ...

Quality of care measures improve performance

March 4, 2013
Public reporting of how physicians and hospitals perform in quality of care measures leads to improved care for patients. A collaborative team of researchers led by Geoffrey C. Lamb, M.D., professor of internal medicine at ...

Full weight-Based chemo doses recommended for obese

April 6, 2012
(HealthDay) -- The American Society of Clinical Oncology Clinical Practice Guideline on Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer recommends using full weight-based cytotoxic chemotherapy doses ...

Urology-owned radiation oncology self-referral can increase patients' travel distance for treatment

August 15, 2012
Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments for their cancer when treated at a urology-owned radiation oncology practice versus other ...

Recommended for you

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.